Cancer Biomarkers

A cancer biomarker refers to a substance or technique this is indicative of the presence of cancer inside the frame. A biomarker may be a molecule secreted via a tumour or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycolic, and imaging biomarkers can be used for cancer prognosis, diagnosis, and epidemiology. Whilst a few most cancers biomarkers can be used to be expecting how aggressively your cancer will develop, and are consequently beneficial for assessing your analysis, the maximum promising use of biomarkers these days is to pick out which cures a patient’s cancer may additionally or might not respond to.

  • Diagnostic Biomarkers
  • Predictive & Prognostic Biomarkers
  • Tumour Suppressors Biomarkers
  • Molecular Cancer Biomarkers

Related Conference of Cancer Biomarkers

March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
April 07-08, 2025

15th World Congress on Breast Cancer

Vancouver, Canada
April 28-29, 2025

35th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain

Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in